男性迟发性性腺功能减退症筛查量表的验证研究现状

Update of Researches on Validation of Screening Scales for Late-onset Hypogonadism in Males

AMS量表和ADAM问卷是目前筛查或诊断迟发性性腺功能减退症(LOH)时应用最广泛、权威性最高的评价工具,重点阐述国内外关于AMS量表和ADAM问卷验证研究的现状和热点,研究者从多种角度、利用多种方法对不同语言版本筛查量表的适用性和有效性进行了验证研究。多数研究结论认为,AMS量表和ADAM问卷是良好的LOH筛查工具,具有普遍的适用性和较高的有效性。指出目前筛查量表验证研究存在的问题和不足。

Nowadays, the aging males＇ symptoms scale （AMS） and the androgen deficiency in the aging males questionnaire （ADAM） are regarded as the most widely used and highest authoritative evaluation tools when screening and diagnosing late-onset ilypogonadism（LOH） in males. This paper discusses importance on the update and hotspot of researches on validation of AMS and ADAM both in domestic and overseas. Numerous researches validated the applicability and validity of different language editions of screening scales from several points of view and through several methods. The conclusions of majority researches believe AMS and ADAM to be one of good tools for LOH screening. Both scales have general applicability and higher validity. In addition, this paper points out the problems and shortcomings on the researches of validation of AMS and ADAM today.